Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-muscle Invasive Bladder Cancer
Related studies linked through entity extraction aliases.
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
"En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study
- Status
- UNKNOWN
- Phase
- PHASE4
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- N/A
CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
- Status
- TERMINATED
- Phase
- PHASE3